Adial PharmaceuticalsADIL
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 13 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($62K), Citadel Advisors ($55K) and Manchester Capital Management LLC ($49K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A205
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $75K |
| Exits | 2 | $31K |
All 13F filers, Q3 2024 → Q4 2024: 129,006 shares bought and 34,320 shares sold, net +94,686 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Geode Capital Management, LLC | 0.00% | Add +36.0% | 61,847 | $62K |
| Citadel Advisors | 0.00% | Add +63.8% | 54,508 | $55K |
| Manchester Capital Management LLC | 0.01% | No change | 48,097 | $49K |
| Renaissance Technologies | 0.00% | New | 47,613 | $48K |
| BlackRock, Inc. | 0.00% | No change | 27,770 | $28K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 27,000 | $27K |
| UBS Group AG | 0.00% | Add +377.3% | 21,018 | $21K |
| SBI Securities Co., Ltd. | 0.00% | — | 937 | $946 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -83.8% | 638 | $644 |
| Wells Fargo & Company | 0.00% | New | 160 | $162 |
| Bank of America Corp. | 0.00% | No change | 52 | $53 |
| Abound Wealth Management | 0.00% | No change | 27 | $28 |
| Morgan Stanley | 0.00% | Reduce -97.1% | 9 | $9 |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.